The global pelvic floor stimulators market is set to witness robust growth, with sales projected to total USD 140.39 million in 2023. The market is poised to expand at an impressive CAGR of 8.8% over the next decade, reaching a valuation of USD 325.41 million by 2033. This substantial growth highlights the rising adoption of pelvic floor stimulators as a solution for improving pelvic health and addressing incontinence issues.
The increasing prevalence of pelvic floor disorders, particularly among aging populations and postpartum women, is a key driver of market demand. Technological advancements in non-invasive and user-friendly devices are making pelvic floor stimulators a preferred choice for patients seeking effective, at-home treatment options. Additionally, growing awareness about the importance of pelvic health is encouraging healthcare providers to recommend these devices, further boosting adoption rates globally.
Emerging economies are witnessing a notable uptick in demand, driven by the expansion of healthcare infrastructure and improved access to advanced medical devices. Meanwhile, established markets in North America and Europe continue to dominate, thanks to high awareness levels and significant investments in innovative product development. With companies focusing on research and development, the market is expected to witness an influx of new and improved devices tailored to diverse consumer needs.
Key Takeaways:
- Market Value Growth: Pelvic floor stimulators market to rise from USD 140.39 million in 2023 to USD 325.41 million by 2033, driven by a CAGR of 8.8%.
- Growing Awareness: Increased awareness of pelvic health and its management is propelling demand globally.
- Technological Advancements: Innovations in non-invasive, portable, and user-friendly devices are accelerating adoption.
- Regional Insights: North America and Europe lead the market, with emerging economies presenting significant growth opportunities.
The market growth in being induced by the following factors:
- Increasing cases of urinary incontinence
- Growing awareness campaigns by different governments and NGOs across the globe
- Constant technical advances in the pelvic floor stimulators
- The high pervasiveness of neurodegenerative diseases
- The rapidly increasing base of the senior population
- Emergence and convenience of home healthcare
- Surging utilization of medical sensors in diverse treatments
Manufacturers Spreading their Presence Worldwide by Expansions, Acquisitions, and New Launches
Manufacturers in the pelvic floor stimulators market are primarily aiming to carry out strategic collaborations while investing in research and development to consolidate growth in a competitive and fragmented market. Key players are also expanding their global and regional presence through product launches, acquisitions, expansions, and upgrading distribution channels to penetrate the pelvic floor stimulators industry.
- For instance, in June 2021, Laborie Medical Technologies, and Urotronic Inc., announced the completion of the First Optilume procedures in the National Health Service (NHS), United Kingdom.
- In March 2019, InControl Medical received FDA approval for the first over-the-counter (OTC) non-implantable muscle stimulator in the United States. It is intended for at-home use for women with stress, mixed bowel, or incontinence urinary incontinence.
- In August 2020, Pelvital announced the FDA clearance for its Flyte intravaginal home-use device for the treatment of stress urinary incontinence patients.
Key Players in the Market
- Medtronic Plc
- Atlantic Therapeutics
- Laborie Inc.
- The Prometheus Group
- Everyway Medical Instruments Co., Ltd.
- KayCo 2 Ltd.
- InControl Medical Ltd.
- Tic Medizintechnik GmbH
- Shenzhen XFT Medical Ltd.
- Chiaro Technology Ltd.
- Zynex Inc.
- Utah Medical Products, Inc.
- Verity Medical Ltd.
A Full Report Overview
Pelvic Floor Stimulators Industry by Category
Product Type:
- Electrical stimulators
- Magnetic Stimulators
Application:
- Urinary Incontinence
- Sexual Dysfunction
- Neurodegenerative Diseases
End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized clinics
- Homecare setting
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube